30-Jun-2015 - SIRION BIOTECH GmbH

SIRION Biotech Plans Opening of a New Office in the Boston Area

SIRION Biotech announced its commitment to open a new office in the vicinity of Boston. The announcement was made during the 2015 BIO International Convention taking place in Philadelphia, Pennsylvania.

SIRION is working with the Massachusetts Life Sciences Center (MLSC) to locate lab and office space for the Company, which will prove to be a pivotal step in SIRION’s U.S. expansion. SIRION’s office in the Boston area will allow direct access to Massachusetts’ vibrant life science community, which includes an increasing number of biotechnology companies and academic researchers working to develop gene therapies and vaccines for a range of diseases.

“We appreciate the assistance from Massachusetts Life Sciences Center in helping us begin building our U.S. operations in the Boston area, during such an exciting time in our industry,” said Dieter Lingelbach, Chief Operating Officer of SIRION Biotech. “We are a growing company, planning to build on the success we’ve had in Europe, Israel and Japan, as we collaborate with many companies pioneering gene therapies.”

“We are pleased to welcome SIRION to Massachusetts, where the gene therapy space continues to receive significant attention from stakeholders in the life sciences due to its potential to cure a variety of diseases,” said Angus McQuilken, MLSC Vice President for Communications & Marketing. “SIRION will be a great addition to this growing part of the Massachusetts life sciences ecosystem.”

Facts, background information, dossiers
  • Sirion Biotech
More about SIRION BIOTECH
  • News

    Creathor Venture and High-Tech Gründerfonds accelerate growth of SIRION BIOTECH with further investment

    In addition to Creathor Venture the investors High-Tech-Gründerfonds, KfW, and Bayernkapital also joined the current round to further fund the young Munich based biotech. SIRION’s core competence lies in the development and marketing of adenoviral and lentiviral vector technologies in the f ... more

  • Companies

    SIRION BIOTECH GmbH

    SIRION Biotech is Europe's leading commercial supplier of viral vectors used for genetic cell modelling, gene target validation and gene therapy- and vaccination studies. Since its foundation in 2007, SIRION’s mission has been to change the paradigm for viral vector supplies. It has the ab ... more